PPIG and non-Hodgkin lymphoma: 458 RA patients treated with MTX found a fivefold increase in NHL and threefold increase in melanoma compared to the general population with age standardisation; however, risk was increased with prior CYP exposure prior to MTX (2.5-fold increase)